1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Soft Tissue Sarcoma Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Local Sarcoma 1.2.3 Metastatic Sarcoma 1.2.4 Other Sarcoma 1.3 Market by Application 1.3.1 Global Soft Tissue Sarcoma Drugs Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Oncology Centers 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Soft Tissue Sarcoma Drugs Market Perspective (2017-2028) 2.2 Soft Tissue Sarcoma Drugs Growth Trends by Region 2.2.1 Soft Tissue Sarcoma Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Soft Tissue Sarcoma Drugs Historic Market Size by Region (2017-2022) 2.2.3 Soft Tissue Sarcoma Drugs Forecasted Market Size by Region (2023-2028) 2.3 Soft Tissue Sarcoma Drugs Market Dynamics 2.3.1 Soft Tissue Sarcoma Drugs Industry Trends 2.3.2 Soft Tissue Sarcoma Drugs Market Drivers 2.3.3 Soft Tissue Sarcoma Drugs Market Challenges 2.3.4 Soft Tissue Sarcoma Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Soft Tissue Sarcoma Drugs Players by Revenue 3.1.1 Global Top Soft Tissue Sarcoma Drugs Players by Revenue (2017-2022) 3.1.2 Global Soft Tissue Sarcoma Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Soft Tissue Sarcoma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Soft Tissue Sarcoma Drugs Revenue 3.4 Global Soft Tissue Sarcoma Drugs Market Concentration Ratio 3.4.1 Global Soft Tissue Sarcoma Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Soft Tissue Sarcoma Drugs Revenue in 2021 3.5 Soft Tissue Sarcoma Drugs Key Players Head office and Area Served 3.6 Key Players Soft Tissue Sarcoma Drugs Product Solution and Service 3.7 Date of Enter into Soft Tissue Sarcoma Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Soft Tissue Sarcoma Drugs Breakdown Data by Type 4.1 Global Soft Tissue Sarcoma Drugs Historic Market Size by Type (2017-2022) 4.2 Global Soft Tissue Sarcoma Drugs Forecasted Market Size by Type (2023-2028) 5 Soft Tissue Sarcoma Drugs Breakdown Data by Application 5.1 Global Soft Tissue Sarcoma Drugs Historic Market Size by Application (2017-2022) 5.2 Global Soft Tissue Sarcoma Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Soft Tissue Sarcoma Drugs Market Size (2017-2028) 6.2 North America Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) 6.3 North America Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Soft Tissue Sarcoma Drugs Market Size (2017-2028) 7.2 Europe Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) 7.3 Europe Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Soft Tissue Sarcoma Drugs Market Size (2017-2028) 8.2 Asia-Pacific Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) 8.3 Asia-Pacific Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Soft Tissue Sarcoma Drugs Market Size (2017-2028) 9.2 Latin America Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) 9.3 Latin America Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Soft Tissue Sarcoma Drugs Market Size (2017-2028) 10.2 Middle East & Africa Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) 10.3 Middle East & Africa Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Detail 11.1.2 Roche Business Overview 11.1.3 Roche Soft Tissue Sarcoma Drugs Introduction 11.1.4 Roche Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.1.5 Roche Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Detail 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Soft Tissue Sarcoma Drugs Introduction 11.2.4 Pfizer Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.2.5 Pfizer Recent Development 11.3 Johnson & Johnson 11.3.1 Johnson & Johnson Company Detail 11.3.2 Johnson & Johnson Business Overview 11.3.3 Johnson & Johnson Soft Tissue Sarcoma Drugs Introduction 11.3.4 Johnson & Johnson Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.3.5 Johnson & Johnson Recent Development 11.4 GSK Plc 11.4.1 GSK Plc Company Detail 11.4.2 GSK Plc Business Overview 11.4.3 GSK Plc Soft Tissue Sarcoma Drugs Introduction 11.4.4 GSK Plc Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.4.5 GSK Plc Recent Development 11.5 Teva Pharmaceuticals 11.5.1 Teva Pharmaceuticals Company Detail 11.5.2 Teva Pharmaceuticals Business Overview 11.5.3 Teva Pharmaceuticals Soft Tissue Sarcoma Drugs Introduction 11.5.4 Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.5.5 Teva Pharmaceuticals Recent Development 11.6 Celgene 11.6.1 Celgene Company Detail 11.6.2 Celgene Business Overview 11.6.3 Celgene Soft Tissue Sarcoma Drugs Introduction 11.6.4 Celgene Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.6.5 Celgene Recent Development 11.7 Bristol Myers Squibb 11.7.1 Bristol Myers Squibb Company Detail 11.7.2 Bristol Myers Squibb Business Overview 11.7.3 Bristol Myers Squibb Soft Tissue Sarcoma Drugs Introduction 11.7.4 Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.7.5 Bristol Myers Squibb Recent Development 11.8 BeiGene 11.8.1 BeiGene Company Detail 11.8.2 BeiGene Business Overview 11.8.3 BeiGene Soft Tissue Sarcoma Drugs Introduction 11.8.4 BeiGene Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.8.5 BeiGene Recent Development 11.9 Shenzhen Chipscreen 11.9.1 Shenzhen Chipscreen Company Detail 11.9.2 Shenzhen Chipscreen Business Overview 11.9.3 Shenzhen Chipscreen Soft Tissue Sarcoma Drugs Introduction 11.9.4 Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.9.5 Shenzhen Chipscreen Recent Development 11.10 Monopar Therapeutics 11.10.1 Monopar Therapeutics Company Detail 11.10.2 Monopar Therapeutics Business Overview 11.10.3 Monopar Therapeutics Soft Tissue Sarcoma Drugs Introduction 11.10.4 Monopar Therapeutics Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.10.5 Monopar Therapeutics Recent Development 11.11 Akeso Biopharma 11.11.1 Akeso Biopharma Company Detail 11.11.2 Akeso Biopharma Business Overview 11.11.3 Akeso Biopharma Soft Tissue Sarcoma Drugs Introduction 11.11.4 Akeso Biopharma Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) 11.11.5 Akeso Biopharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Soft Tissue Sarcoma Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Local Sarcoma Table 3. Key Players of Metastatic Sarcoma Table 4. Key Players of Other Sarcoma Table 5. Global Soft Tissue Sarcoma Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Soft Tissue Sarcoma Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Soft Tissue Sarcoma Drugs Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Soft Tissue Sarcoma Drugs Market Share by Region (2017-2022) Table 9. Global Soft Tissue Sarcoma Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Soft Tissue Sarcoma Drugs Market Share by Region (2023-2028) Table 11. Soft Tissue Sarcoma Drugs Market Trends Table 12. Soft Tissue Sarcoma Drugs Market Drivers Table 13. Soft Tissue Sarcoma Drugs Market Challenges Table 14. Soft Tissue Sarcoma Drugs Market Restraints Table 15. Global Soft Tissue Sarcoma Drugs Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Soft Tissue Sarcoma Drugs Market Share by Players (2017-2022) Table 17. Global Top Soft Tissue Sarcoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Drugs as of 2021) Table 18. Ranking of Global Top Soft Tissue Sarcoma Drugs Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Soft Tissue Sarcoma Drugs Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Soft Tissue Sarcoma Drugs Product Solution and Service Table 22. Date of Enter into Soft Tissue Sarcoma Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Soft Tissue Sarcoma Drugs Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Soft Tissue Sarcoma Drugs Revenue Market Share by Type (2017-2022) Table 26. Global Soft Tissue Sarcoma Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Soft Tissue Sarcoma Drugs Revenue Market Share by Type (2023-2028) Table 28. Global Soft Tissue Sarcoma Drugs Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Soft Tissue Sarcoma Drugs Revenue Market Share by Application (2017-2022) Table 30. Global Soft Tissue Sarcoma Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Soft Tissue Sarcoma Drugs Revenue Market Share by Application (2023-2028) Table 32. North America Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Soft Tissue Sarcoma Drugs Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Soft Tissue Sarcoma Drugs Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Soft Tissue Sarcoma Drugs Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Soft Tissue Sarcoma Drugs Market Size by Country (2023-2028) & (US$ Million) Table 42. Roche Company Detail Table 43. Roche Business Overview Table 44. Roche Soft Tissue Sarcoma Drugs Product Table 45. Roche Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 46. Roche Recent Development Table 47. Pfizer Company Detail Table 48. Pfizer Business Overview Table 49. Pfizer Soft Tissue Sarcoma Drugs Product Table 50. Pfizer Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 51. Pfizer Recent Development Table 52. Johnson & Johnson Company Detail Table 53. Johnson & Johnson Business Overview Table 54. Johnson & Johnson Soft Tissue Sarcoma Drugs Product Table 55. Johnson & Johnson Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 56. Johnson & Johnson Recent Development Table 57. GSK Plc Company Detail Table 58. GSK Plc Business Overview Table 59. GSK Plc Soft Tissue Sarcoma Drugs Product Table 60. GSK Plc Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 61. GSK Plc Recent Development Table 62. Teva Pharmaceuticals Company Detail Table 63. Teva Pharmaceuticals Business Overview Table 64. Teva Pharmaceuticals Soft Tissue Sarcoma Drugs Product Table 65. Teva Pharmaceuticals Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 66. Teva Pharmaceuticals Recent Development Table 67. Celgene Company Detail Table 68. Celgene Business Overview Table 69. Celgene Soft Tissue Sarcoma Drugs Product Table 70. Celgene Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 71. Celgene Recent Development Table 72. Bristol Myers Squibb Company Detail Table 73. Bristol Myers Squibb Business Overview Table 74. Bristol Myers Squibb Soft Tissue Sarcoma Drugs Product Table 75. Bristol Myers Squibb Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 76. Bristol Myers Squibb Recent Development Table 77. BeiGene Company Detail Table 78. BeiGene Business Overview Table 79. BeiGene Soft Tissue Sarcoma Drugs Product Table 80. BeiGene Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 81. BeiGene Recent Development Table 82. Shenzhen Chipscreen Company Detail Table 83. Shenzhen Chipscreen Business Overview Table 84. Shenzhen Chipscreen Soft Tissue Sarcoma Drugs Product Table 85. Shenzhen Chipscreen Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 86. Shenzhen Chipscreen Recent Development Table 87. Monopar Therapeutics Company Detail Table 88. Monopar Therapeutics Business Overview Table 89. Monopar Therapeutics Soft Tissue Sarcoma Drugs Product Table 90. Monopar Therapeutics Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 91. Monopar Therapeutics Recent Development Table 92. Akeso Biopharma Company Detail Table 93. Akeso Biopharma Business Overview Table 94. Akeso Biopharma Soft Tissue Sarcoma DrugsProduct Table 95. Akeso Biopharma Revenue in Soft Tissue Sarcoma Drugs Business (2017-2022) & (US$ Million) Table 96. Akeso Biopharma Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Soft Tissue Sarcoma Drugs Market Share by Type: 2021 VS 2028 Figure 2. Local Sarcoma Features Figure 3. Metastatic Sarcoma Features Figure 4. Other Sarcoma Features Figure 5. Global Soft Tissue Sarcoma Drugs Market Share by Application in 2021 & 2028 Figure 6. Hospitals Case Studies Figure 7. Oncology Centers Case Studies Figure 8. Other Case Studies Figure 9. Soft Tissue Sarcoma Drugs Report Years Considered Figure 10. Global Soft Tissue Sarcoma Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Soft Tissue Sarcoma Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Soft Tissue Sarcoma Drugs Market Share by Region: 2021 VS 2028 Figure 13. Global Soft Tissue Sarcoma Drugs Market Share by Players in 2021 Figure 14. Global Top Soft Tissue Sarcoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Sarcoma Drugs as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Soft Tissue Sarcoma Drugs Revenue in 2021 Figure 16. North America Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Soft Tissue Sarcoma Drugs Market Share by Country (2017-2028) Figure 18. United States Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Soft Tissue Sarcoma Drugs Market Share by Country (2017-2028) Figure 22. Germany Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Soft Tissue Sarcoma Drugs Market Share by Region (2017-2028) Figure 30. China Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Soft Tissue Sarcoma Drugs Market Share by Country (2017-2028) Figure 38. Mexico Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Soft Tissue Sarcoma Drugs Market Share by Country (2017-2028) Figure 42. Turkey Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Soft Tissue Sarcoma Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Roche Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 45. Pfizer Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 46. Johnson & Johnson Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 47. GSK Plc Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 48. Teva Pharmaceuticals Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 49. Celgene Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 50. Bristol Myers Squibb Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 51. BeiGene Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 52. Shenzhen Chipscreen Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 53. Monopar Therapeutics Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 54. Akeso Biopharma Revenue Growth Rate in Soft Tissue Sarcoma Drugs Business (2017-2022) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Roche Pfizer Johnson & Johnson GSK Plc Teva Pharmaceuticals Celgene Bristol Myers Squibb BeiGene Shenzhen Chipscreen Monopar Therapeutics Akeso Biopharma